DOSSIER · 13F-HR · Q1 2026

KVP Capital Advisors, LP

$134M in tracked AUM across 32 positions as of Q1 2026.

KC
CIK 0001858198 · last filed Mar 31, 2026
Total AUM
$134M
as of Q1 2026
Holdings
32
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

KVP Capital Advisors, LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
TERN
TERNS PHARMACEUTICALS INC
$23M440K17.3%
02
PRAX
PRAXIS PRECISION MEDICINES I
$14M43K10.3%
03
WHWK
WHITEHAWK THERAPEUTICS INC
$7M2.2M5.6%
04
AXSM
AXSOME THERAPEUTICS INC
$6M36K4.6%
05
STRO
SUTRO BIOPHARMA INC
$6M227K4.2%
06
PTGX
PROTAGONIST THERAPEUTICS INC
$6M53K4.2%
07
ERAS
ERASCA INC
$6M340K4.1%
08
TRVI
TREVI THERAPEUTICS INC
$5M414K3.7%
09
TNGX
TANGO THERAPEUTICS INC
$5M230K3.6%
10
INSM
INSMED INC
$5M28K3.5%

Filing history

2026Q1Mar 31
$134M 29.6%
32 positionsView →
2025Q4Dec 31
$103M
27 positionsView →